| BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
20 |
|
serial mean |
25.0 |
mmHg |
3.0 |
13.42 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
|
|
|
|
67303 |
151 |
| SS/JrHsdMcwi |
absolute change in mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
9 |
|
serial mean |
24.0 |
mmHg |
4.0 |
12.0 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
|
|
|
|
67304 |
151 |
| LEW/Cub |
both kidneys wet weight to body weight ratio |
losartan (10 mg/kg) (for 0.2 hours) then pentolinium (5 mg/kg) (for 0.1 hours) then NG-nitroarginine methyl ester (30 mg/kg) (for 0.3 hours) |
Ueno T, et al., Physiol Res 2003;52(6):689-700. |
kidney mass |
not specified |
days
| 9 |
|
serial mean |
6.84 |
g/kg |
|
|
post excision weight measurement |
|
0 |
|
|
|
|
|
65427 |
568 |
| SS.BN-(D13Hmgc41-D13Hmgc23)/Mcwi |
resting tone of middle cerebral artery |
controlled calcium ion content physiological salt solution perfusate (0 %) then NG-nitroarginine methyl ester (100 umol/l) (for 0.3 hours) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63.0 days-98.0 days |
7 |
[(Dmax - Drest) /Dmax] x 100 |
|
49.0 |
% |
2.4 |
6.35 |
ex vivo videomicroscopy |
|
0.0 |
|
|
|
|
|
69557 |
732 |
| SS/Jr |
logarithm of the concentration of angiotensin II at which the force of blood vessel contraction is half the maximum value (Log EC50) |
Kreb's solution perfusate then angiotensin II (0.3-300 umol/l) then NG-nitroarginine methyl ester (100 umol/l) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
vasoconstriction trait |
male |
98.0 days
| 12 |
|
|
-7.92 |
null |
0.36 |
1.25 |
tissue force analysis utilizing a force transducer |
|
0.0 |
|
|
|
isometric force transducer |
|
69071 |
1096 |
| SS.MNS-(D2Mit6-D2Rat303)/Ayd |
receptor-dependent blood vessel maximum contractile force to receptor-independent blood vessel maximum contractile force ratio |
Kreb's solution perfusate then phenylephrine (1-100 mmol/l) and NG-nitroarginine methyl ester (100 umol/l) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
vasoconstriction trait |
male |
98.0 days
| 13 |
|
|
143.03 |
% |
6.62 |
23.87 |
tissue force analysis utilizing a force transducer |
|
0.0 |
|
|
|
isometric force transducer |
|
69057 |
1096 |
| SS/JrHsdMcwi |
middle cerebral artery inner diameter |
angiotensin II (3 ng/kg/min) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) then NG-nitroarginine methyl ester (100 umol/l) (for 0.3 hours) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63.0 days-98.0 days |
5 |
|
|
246.0 |
um |
3.7 |
8.27 |
ex vivo videomicroscopy |
|
0.0 |
|
|
|
|
|
69577 |
732 |
| SS/JrHsdMcwi |
resting tone of middle cerebral artery |
angiotensin II (3 ng/kg/min) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) then NG-nitroarginine methyl ester (100 umol/l) (for 0.3 hours) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63.0 days-98.0 days |
5 |
[(Dmax - Drest) /Dmax] x 100 |
|
54.0 |
% |
2.2 |
4.92 |
ex vivo videomicroscopy |
|
0.0 |
|
|
|
|
|
69578 |
732 |
| SS/JrHsdMcwi |
resting tone of middle cerebral artery |
controlled tempol content drinking water (15 mg/kg/d) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) then NG-nitroarginine methyl ester (100 umol/l) (for 0.3 hours) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63.0 days-98.0 days |
6 |
[(Dmax - Drest) /Dmax] x 100 |
|
44.0 |
% |
3.3 |
8.08 |
ex vivo videomicroscopy |
|
0.0 |
|
|
|
|
|
69587 |
732 |
| BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) then acetylcholine (0.1 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
21 |
|
serial mean |
138.6 |
mmHg |
3.8 |
17.41 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
|
|
69547 |
151 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) then acetylcholine (0.2 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
9 |
|
serial mean |
159.1 |
mmHg |
6.4 |
19.2 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
|
|
69550 |
151 |
| ACI/Eur |
body weight |
right nephrectomy then NG-nitroarginine methyl ester (50-150 mg/l) |
Van Dijk SJ, et al., Kidney Int. 2006 |
body mass |
male |
168.0 days-175.0 days |
12 |
|
|
314.0 |
g |
6.0 |
20.78 |
body weighing method |
|
0.0 |
|
|
|
|
|
67704 |
62 |
| ACI.FHH-(D1Rat475-D1Rat90)(D3Rat84-D3Rat59)/Eur |
body weight |
NG-nitroarginine methyl ester (50-150 mg/l) |
Van Dijk SJ, et al., Kidney Int. 2006 |
body mass |
male |
168.0 days-175.0 days |
12 |
|
|
296.0 |
g |
6.0 |
20.78 |
body weighing method |
|
0.0 |
|
|
|
|
|
67703 |
62 |
| ACI.FHH-(D1Rat298-D1Rat90)/Eur |
body weight |
right nephrectomy then NG-nitroarginine methyl ester (50-150 mg/l) |
Van Dijk SJ, et al., Kidney Int. 2006 |
body mass |
male |
168.0 days-175.0 days |
12 |
|
|
319.0 |
g |
6.0 |
20.78 |
body weighing method |
|
0.0 |
|
|
|
|
|
67706 |
62 |
| ACI.FHH-(D3Wox2-D3Rat59)/Eur |
kidney sclerotic glomeruli count to total glomeruli count ratio |
NG-nitroarginine methyl ester (50-150 mg/l) |
Van Dijk SJ, et al., Kidney Int. 2006 |
kidney glomerulus integrity trait |
male |
168.0 days-175.0 days |
12 |
|
|
18.0 |
% |
2.0 |
6.93 |
ex vivo light microscopy |
|
0.0 |
|
|
|
|
|
67714 |
62 |
| ACI.FHH-(D1Rat298-D1Rat90)/Eur |
kidney sclerotic glomeruli count to total glomeruli count ratio |
right nephrectomy then NG-nitroarginine methyl ester (50-150 mg/l) |
Van Dijk SJ, et al., Kidney Int. 2006 |
kidney glomerulus integrity trait |
male |
168.0 days-175.0 days |
12 |
|
|
37.0 |
% |
4.0 |
13.86 |
ex vivo light microscopy |
|
0.0 |
|
|
|
|
|
67724 |
62 |
| ACI.FHH-(D1Rat475-D1Rat90)(D3Rat84-D3Rat59)/Eur |
kidney sclerotic glomeruli count to total glomeruli count ratio |
right nephrectomy then NG-nitroarginine methyl ester (50-150 mg/l) |
Van Dijk SJ, et al., Kidney Int. 2006 |
kidney glomerulus integrity trait |
male |
168.0 days-175.0 days |
5 |
|
|
64.0 |
% |
11.0 |
24.6 |
ex vivo light microscopy |
|
0.0 |
|
|
|
|
|
67725 |
62 |
| ACI/Eur |
creatinine clearance to body weight ratio |
NG-nitroarginine methyl ester (50-150 mg/l) |
Van Dijk SJ, et al., Kidney Int. 2006 |
glomerular filtration trait |
male |
168.0 days-175.0 days |
12 |
|
|
0.5 |
ml/min/100g |
0.02 |
0.07 |
blood creatinine analysis |
|
0.0 |
|
|
|
|
|
67730 |
62 |
| ACI.FHH-(D1Rat384-D1Rat452)(D17Rat61-D1Arb5)(D17Rat51)/Eur |
kidney sclerotic glomeruli count to total glomeruli count ratio |
unilateral nephrectomy then NG-nitroarginine methyl ester (10-21 mg/kg/d) (for 126 days) |
van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12. |
kidney glomerulus integrity trait |
not specified |
168.0 days-175.0 days |
9 |
|
|
29.0 |
% |
4.0 |
12.0 |
ex vivo light microscopy |
|
0.0 |
unilateral nephrectomy |
126 |
days |
|
Original CMO_ID, CMO:0001176, was merged into current ID and field automatically updated. 4-26-2013 |
68885 |
832 |
| SS/HsdMcwiCrl |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled carbohydrate content diet (69 %) (for 63 days) and controlled fat content diet (12 %) (for 63 days) and controlled protein content diet (19 %) (for 63 days) then controlled carbohydrate content diet (53 %) (for 28 days) and controlled fat content diet (14 %) (for 28 days) and controlled protein content diet (33 %) (for 28 days) then phenylephrine (2 umol/l) then NG-nitroarginine methyl ester (100 umol/l) then acetylcholine (0.001-9.5 umol/l) |
Spradley FT, et al., Am J Physiol Regul Integr Comp Physiol. 2012 Jan 1;302(1):R150-8. Epub 2011 Oct 26. |
vasodilation trait |
male |
112.0 days
| 5 |
logEC50 |
|
-6.7 |
null |
0.2 |
0.45 |
wire myography |
mesenteric artery |
0.0 |
|
|
|
|
|
84647 |
735 |
| SS/HsdMcwiCrl |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled carbohydrate content diet (69 %) (for 91 days) and controlled fat content diet (12 %) (for 91 days) and controlled protein content diet (19 %) (for 91 days) then phenylephrine (1 umol/l) then NG-nitroarginine methyl ester (100 umol/l) then acetylcholine (31.6 umol/l) |
Spradley FT, et al., Am J Physiol Regul Integr Comp Physiol. 2012 Jan 1;302(1):R150-8. Epub 2011 Oct 26. |
vasodilation trait |
male |
112.0 days
| 7 |
[(maximum PE response − ACh response)/(maximum PE response − baseline before PE constriction)] × 100 |
|
-12.94 |
% |
4.38 |
11.59 |
wire myography |
aorta |
0.0 |
|
|
|
|
|
84658 |
735 |
| SS/HsdMcwiCrl |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled carbohydrate content diet (53 %) (for 63 days) and controlled fat content diet (14 %) (for 63 days) and controlled protein content diet (33 %) (for 63 days) then controlled carbohydrate content diet (69 %) (for 28 days) and controlled fat content diet (12 %) (for 28 days) and controlled protein content diet (19 %) (for 28 days) then phenylephrine (1 umol/l) then NG-nitroarginine methyl ester (100 umol/l) then acetylcholine (31.6 umol/l) |
Spradley FT, et al., Am J Physiol Regul Integr Comp Physiol. 2012 Jan 1;302(1):R150-8. Epub 2011 Oct 26. |
vasodilation trait |
male |
112.0 days
| 10 |
[(maximum PE response − ACh response)/(maximum PE response − baseline before PE constriction)] × 100 |
|
-29.33 |
% |
4.38 |
13.85 |
wire myography |
aorta |
0.0 |
|
|
|
|
|
84657 |
735 |
| SS/HsdMcwiCrl |
phenylephrine-induced blood vessel contractile force expressed as percent of force at baseline |
controlled carbohydrate content diet (53 %) (for 91 days) and controlled fat content diet (14 %) (for 91 days) and controlled protein content diet (33 %) (for 91 days) then NG-nitroarginine methyl ester (100 umol/l) (for 0.2 hours) then phenylephrine (31.6 umol/l) |
Spradley FT, et al., Am J Physiol Regul Integr Comp Physiol. 2012 Jan 1;302(1):R150-8. Epub 2011 Oct 26. |
vasoconstriction trait |
male |
112.0 days
| 7 |
[(response to vasoconstrictor - baseline before constriction)/baseline before constriction] x 100 |
|
756.89 |
% |
61.56 |
162.87 |
wire myography |
mesenteric artery |
0.0 |
|
|
|
|
phenylephrine-induced blood vessel constriction expressed as percent of force at baseline |
84676 |
735 |
| Crlj:WI |
mean arterial blood pressure |
controlled air oxygen content (21 %) (for 28 days) then vehicle control condition (0.15 ml) (for 0.1 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) then sodium nitroprusside (5 ug/kg/min) (for 0.1 hours) then NG-nitroarginine methyl ester (50 mg/kg) (for 0.5 hours) and meclofenamate (3 mg/kg) (for 0.5 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
arterial blood pressure trait |
male |
16.0 days
| 6 |
undefined |
|
120.0 |
mmHg |
7.0 |
17.15 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
103031 |
2784 |
| Crlj:WI |
heart rate |
controlled air oxygen content (5 %) (for 28 days) then vehicle control condition (0.15 ml) (for 0.1 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) then sodium nitroprusside (5 ug/kg/min) (for 0.1 hours) then NG-nitroarginine methyl ester (50 mg/kg) (for 0.5 hours) and meclofenamate (3 mg/kg) (for 0.5 hours) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
heart pumping trait |
male |
16.0 days
| 7 |
|
|
287.0 |
beats/min |
7.0 |
18.52 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
103048 |
2784 |
| Crlj:WI |
heart rate |
controlled air oxygen content (21 %) (for 28 days) then vehicle control condition (0.15 ml) (for 0.1 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) then sodium nitroprusside (5 ug/kg/min) (for 0.1 hours) then NG-nitroarginine methyl ester (50 mg/kg) (for 0.5 hours) and meclofenamate (3 mg/kg) (for 0.5 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
heart pumping trait |
male |
16.0 days
| 6 |
|
|
275.0 |
beats/min |
8.0 |
19.6 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
103051 |
2784 |
| ACI/EurMcwi |
urine total protein excretion rate |
unilateral nephrectomy then NG-nitroarginine methyl ester (150 mg/l) (for 56 days) |
Lazar J, et al., Physiol Genomics. 2013 Aug 15;45(16):720-8. doi: 10.1152/physiolgenomics.00089.2013. Epub 2013 Jun 18. |
total urine protein amount |
male |
91.0 days
| 9 |
|
|
68.52 |
mg/d |
7.28 |
21.84 |
urine protein analysis |
|
0.0 |
unx |
56 |
days |
|
rf-1-1 |
100051 |
2400 |
| ACI.FHH-(rs105487995-rs106411696)/Mcwi |
urine total protein excretion rate |
unilateral nephrectomy then NG-nitroarginine methyl ester (150 mg/l) (for 56 days) |
Lazar J, et al., Physiol Genomics. 2013 Aug 15;45(16):720-8. doi: 10.1152/physiolgenomics.00089.2013. Epub 2013 Jun 18. |
total urine protein amount |
male |
91.0 days
| 8 |
|
|
81.88 |
mg/d |
16.62 |
47.01 |
urine protein analysis |
|
0.0 |
unx |
56 |
days |
|
rf-1-2 |
100053 |
2400 |
| ACI/EurMcwi |
urine albumin excretion rate |
unilateral nephrectomy then NG-nitroarginine methyl ester (150 mg/l) (for 56 days) |
Lazar J, et al., Physiol Genomics. 2013 Aug 15;45(16):720-8. doi: 10.1152/physiolgenomics.00089.2013. Epub 2013 Jun 18. |
urine albumin amount |
male |
91.0 days
| 9 |
|
|
19.16 |
mg/d |
5.53 |
16.59 |
urine albumin analysis |
|
0.0 |
unx |
56 |
days |
|
|
100059 |
2400 |
| ACI.FHH-(rs105373896-rgdv253272372)/Mcwi |
urine total protein excretion rate |
unilateral nephrectomy then NG-nitroarginine methyl ester (150 mg/l) (for 56 days) |
Lazar J, et al., Physiol Genomics. 2013 Aug 15;45(16):720-8. doi: 10.1152/physiolgenomics.00089.2013. Epub 2013 Jun 18. |
total urine protein amount |
male |
91.0 days
| 6 |
|
|
41.34 |
mg/d |
4.81 |
11.78 |
urine protein analysis |
|
0.0 |
unx |
56 |
days |
|
rf-1-6 |
100057 |
2400 |
| ACI.FHH-(rgdv393055223-rs107095981)/Mcwi |
urine albumin excretion rate |
unilateral nephrectomy then NG-nitroarginine methyl ester (150 mg/l) (for 56 days) |
Lazar J, et al., Physiol Genomics. 2013 Aug 15;45(16):720-8. doi: 10.1152/physiolgenomics.00089.2013. Epub 2013 Jun 18. |
urine albumin amount |
male |
91.0 days
| 5 |
|
|
93.07 |
mg/d |
13.96 |
31.22 |
urine albumin analysis |
|
0.0 |
unx |
56 |
days |
|
rf-1-3 |
100062 |
2400 |
| ACI.FHH-(rs105373896-rgdv253272372)/Mcwi |
urine albumin excretion rate |
unilateral nephrectomy then NG-nitroarginine methyl ester (150 mg/l) (for 56 days) |
Lazar J, et al., Physiol Genomics. 2013 Aug 15;45(16):720-8. doi: 10.1152/physiolgenomics.00089.2013. Epub 2013 Jun 18. |
urine albumin amount |
male |
91.0 days
| 6 |
|
|
16.35 |
mg/d |
3.01 |
7.37 |
urine albumin analysis |
|
0.0 |
unx |
56 |
days |
|
rf-1-6 |
100065 |
2400 |
| LEW |
mean arterial blood pressure |
losartan (10 mg/kg) (for 0.2 hours) then pentolinium (5 mg/kg) (for 0.1 hours) then NG-nitroarginine methyl ester (30 mg/kg) (for 0.3 hours) |
Ueno T, et al., J Mol Med 2003 Jan;81(1):51-60. Epub 2002 Nov 21. |
arterial blood pressure trait |
both |
151.0 days-181.0 days |
21 |
|
continuous mean |
123.0 |
mmHg |
5.0 |
22.91 |
vascular indwelling catheter method |
carotid artery, jugular vein |
1800 |
|
|
|
|
|
64706 |
249 |
| LEW/Cub |
systolic blood pressure |
losartan (10 mg/kg) (for 0.2 hours) then pentolinium (5 mg/kg) (for 0.1 hours) then NG-nitroarginine methyl ester (30 mg/kg) (for 0.3 hours) |
Ueno T, et al., Physiol Res 2003;52(6):689-700. |
arterial blood pressure trait |
not specified |
days
| 9 |
|
continuous mean |
128.5 |
mmHg |
|
|
vascular indwelling catheter method |
|
|
|
|
|
|
|
65383 |
568 |
| HTG |
heart weight to body weight ratio |
losartan (10 mg/kg) (for 0.2 hours) then pentolinium (5 mg/kg) (for 0.1 hours) then NG-nitroarginine methyl ester (30 mg/kg) (for 0.3 hours) |
Ueno T, et al., Physiol Res 2003;52(6):689-700. |
heart mass |
not specified |
days
| 10 |
|
|
2.67 |
g/kg |
|
|
post excision weight measurement |
|
0 |
|
|
|
|
|
65404 |
568 |
| HTG |
body weight |
losartan (10 mg/kg) (for 0.2 hours) then pentolinium (5 mg/kg) (for 0.1 hours) then NG-nitroarginine methyl ester (30 mg/kg) (for 0.3 hours) |
Ueno T, et al., Physiol Res 2003;52(6):689-700. |
body mass |
not specified |
days
| 10 |
|
serial mean |
309.3 |
g |
|
|
body weighing method |
|
0 |
|
|
|
|
|
65438 |
568 |
| LEW/Cub |
body weight |
losartan (10 mg/kg) (for 0.2 hours) then pentolinium (5 mg/kg) (for 0.1 hours) then NG-nitroarginine methyl ester (30 mg/kg) (for 0.3 hours) |
Ueno T, et al., Physiol Res 2003;52(6):689-700. |
body mass |
not specified |
days
| 9 |
|
serial mean |
300.2 |
g |
|
|
body weighing method |
|
0 |
|
|
|
|
|
65439 |
568 |
| SS.MNS-(D2Mit6-D2Rat303)/Ayd |
logarithm of the concentration of angiotensin II at which the force of blood vessel contraction is half the maximum value (Log EC50) |
Kreb's solution perfusate then angiotensin II (0.3-300 umol/l) and NG-nitroarginine methyl ester (100 umol/l) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
vasoconstriction trait |
male |
98.0 days
| 13 |
|
|
-7.2 |
null |
0.31 |
1.12 |
tissue force analysis utilizing a force transducer |
|
0.0 |
|
|
|
isometric force transducer |
|
69072 |
1096 |
| SS/Jr |
receptor-dependent blood vessel maximum contractile force to receptor-independent blood vessel maximum contractile force ratio |
Kreb's solution perfusate then phenylephrine (1-100 mmol/l) and NG-nitroarginine methyl ester (100 umol/l) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
vasoconstriction trait |
male |
98.0 days
| 12 |
|
|
141.72 |
% |
7.73 |
26.78 |
tissue force analysis utilizing a force transducer |
|
0.0 |
|
|
|
isometric force transducer |
|
69056 |
1096 |
| SS/JrHsdMcwi |
middle cerebral artery inner diameter |
angiotensin II (3 ng/kg/min) (for 3 days) then physiological salt solution perfusate then NG-nitroarginine methyl ester (100 umol/l) (for 0.3 hours) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63.0 days-98.0 days |
5 |
|
|
113.0 |
um |
4.2 |
9.39 |
ex vivo videomicroscopy |
|
0.0 |
|
|
|
|
|
69576 |
732 |
| SS/JrHsdMcwi |
middle cerebral artery inner diameter |
controlled tempol content drinking water (15 mg/kg/d) (for 3 days) then physiological salt solution perfusate then NG-nitroarginine methyl ester (100 umol/l) (for 0.3 hours) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63.0 days-98.0 days |
6 |
|
|
138.0 |
um |
10.1 |
24.74 |
ex vivo videomicroscopy |
|
0.0 |
|
|
|
|
|
69585 |
732 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) then acetylcholine (0.1 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
9 |
|
serial mean |
160.0 |
mmHg |
6.7 |
20.1 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
|
|
69548 |
151 |
| ACI.FHH-(D1Rat384-D1Rat156)/Eur |
body weight |
unilateral nephrectomy then NG-nitroarginine methyl ester (10-21 ml/kg/d) (for 126 days) |
van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12. |
body mass |
not specified |
168.0 days-175.0 days |
11 |
|
|
267.0 |
g |
11.0 |
36.48 |
body weighing method |
|
0.0 |
unilateral nephrectomy |
126 |
days |
|
|
67908 |
832 |
| SS/HsdMcwiCrl |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled carbohydrate content diet (69 %) (for 91 days) and controlled fat content diet (12 %) (for 91 days) and controlled protein content diet (19 %) (for 91 days) then phenylephrine (2 umol/l) then NG-nitroarginine methyl ester (100 umol/l) then acetylcholine (3.16 umol/l) |
Spradley FT, et al., Am J Physiol Regul Integr Comp Physiol. 2012 Jan 1;302(1):R150-8. Epub 2011 Oct 26. |
vasodilation trait |
male |
112.0 days
| 6 |
[(maximum PE response − ACh response)/(maximum PE response − baseline before PE constriction)] × 100 |
|
91.96 |
% |
2.76 |
6.76 |
wire myography |
mesenteric artery |
0.0 |
|
|
|
|
|
69622 |
735 |
| ACI.FHH-(D3Wox2-D3Rat59)/Eur |
body weight |
NG-nitroarginine methyl ester (50-150 mg/l) |
Van Dijk SJ, et al., Kidney Int. 2006 |
body mass |
male |
168.0 days-175.0 days |
12 |
|
|
321.0 |
g |
4.0 |
13.86 |
body weighing method |
|
0.0 |
|
|
|
|
|
67701 |
62 |
| ACI.FHH-(D3Wox2-D3Rat59)/Eur |
body weight |
right nephrectomy then NG-nitroarginine methyl ester (50-150 mg/l) |
Van Dijk SJ, et al., Kidney Int. 2006 |
body mass |
male |
168.0 days-175.0 days |
11 |
|
|
301.0 |
g |
6.0 |
19.9 |
body weighing method |
|
0.0 |
|
|
|
|
|
67705 |
62 |
| ACI.FHH-(D1Rat298-D1Rat90)/Eur |
body weight |
NG-nitroarginine methyl ester (50-150 mg/l) |
Van Dijk SJ, et al., Kidney Int. 2006 |
body mass |
male |
168.0 days-175.0 days |
12 |
|
|
328.0 |
g |
3.0 |
10.39 |
body weighing method |
|
0.0 |
|
|
|
|
|
67702 |
62 |
| ACI/Eur |
kidney sclerotic glomeruli count to total glomeruli count ratio |
NG-nitroarginine methyl ester (50-150 mg/l) |
Van Dijk SJ, et al., Kidney Int. 2006 |
kidney glomerulus integrity trait |
male |
168.0 days-175.0 days |
12 |
|
|
11.0 |
% |
1.0 |
3.46 |
ex vivo light microscopy |
|
0.0 |
|
|
|
|
|
67712 |
62 |
| ACI.FHH-(D1Mit18-D1Mit8)(D14Mit11-D14Hmgc14b)(D14Rat65-D14Rat90)/Eur |
kidney sclerotic glomeruli count to total glomeruli count ratio |
unilateral nephrectomy then NG-nitroarginine methyl ester (10-21 mg/kg/d) (for 126 days) |
van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12. |
kidney glomerulus integrity trait |
not specified |
168.0 days-175.0 days |
2 |
|
|
59.0 |
% |
11.0 |
15.56 |
ex vivo light microscopy |
|
0.0 |
unilateral nephrectomy |
126 |
days |
|
Original CMO_ID, CMO:0001176, was merged into current ID and field automatically updated. 4-26-2013 |
68884 |
832 |
| ACI/Eur |
kidney sclerotic glomeruli count to total glomeruli count ratio |
unilateral nephrectomy then NG-nitroarginine methyl ester (10-21 mg/kg/d) (for 126 days) |
van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12. |
kidney glomerulus integrity trait |
not specified |
168.0 days-175.0 days |
12 |
|
|
20.0 |
% |
3.0 |
10.39 |
ex vivo light microscopy |
|
0.0 |
unilateral nephrectomy |
126 |
days |
|
Original CMO_ID, CMO:0001176, was merged into current ID and field automatically updated. 4-26-2013 |
68882 |
832 |
| ACI.FHH-(D1Rat384-D1Rat156)/Eur |
kidney sclerotic glomeruli count to total glomeruli count ratio |
NG-nitroarginine methyl ester (9-16 mg/kg/d) (for 126 days) |
van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12. |
kidney glomerulus integrity trait |
not specified |
168.0 days-175.0 days |
12 |
|
|
20.0 |
% |
3.0 |
10.39 |
ex vivo light microscopy |
|
0.0 |
|
|
|
|
Original CMO_ID, CMO:0001176, was merged into current ID and field automatically updated. 4-26-2013 |
68887 |
832 |
| SS/HsdMcwiCrl |
phenylephrine-induced blood vessel contractile force expressed as percent of force at baseline |
controlled carbohydrate content diet (53 %) (for 63 days) and controlled fat content diet (14 %) (for 63 days) and controlled protein content diet (33 %) (for 63 days) then controlled carbohydrate content diet (69 %) (for 28 days) and controlled fat content diet (12 %) (for 28 days) and controlled protein content diet (19 %) (for 28 days) then NG-nitroarginine methyl ester (100 umol/l) (for 0.2 hours) then phenylephrine (31.6 umol/l) |
Spradley FT, et al., Am J Physiol Regul Integr Comp Physiol. 2012 Jan 1;302(1):R150-8. Epub 2011 Oct 26. |
vasoconstriction trait |
male |
112.0 days
| 9 |
[(response to vasoconstrictor - baseline before constriction)/baseline before constriction] x 100 |
|
626.89 |
% |
61.39 |
184.17 |
wire myography |
mesenteric artery |
0.0 |
|
|
|
|
phenylephrine-induced blood vessel constriction expressed as percent of force at baseline |
84677 |
735 |
| Crlj:WI |
mean arterial blood pressure |
controlled air oxygen content (5 %) (for 28 days) then vehicle control condition (0.15 ml) (for 0.1 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) then sodium nitroprusside (5 ug/kg/min) (for 0.1 hours) then NG-nitroarginine methyl ester (50 mg/kg) (for 0.5 hours) and meclofenamate (3 mg/kg) (for 0.5 hours) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
arterial blood pressure trait |
male |
16.0 days
| 7 |
undefined |
|
136.0 |
mmHg |
13.0 |
34.39 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
103028 |
2784 |
| Crlj:WI |
mean arterial blood pressure |
controlled air oxygen content (5 %) (for 28 days) then vehicle control condition (0.15 ml) (for 0.1 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) then sodium nitroprusside (5 ug/kg/min) (for 0.1 hours) then NG-nitroarginine methyl ester (50 mg/kg) (for 0.5 hours) and meclofenamate (3 mg/kg) (for 0.5 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
arterial blood pressure trait |
male |
16.0 days
| 7 |
undefined |
|
102.0 |
mmHg |
11.0 |
29.1 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
103032 |
2784 |
| GK |
mean arterial blood pressure |
controlled air oxygen content (21 %) (for 28 days) then vehicle control condition (0.15 ml) (for 0.1 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) then sodium nitroprusside (5 ug/kg/min) (for 0.1 hours) then NG-nitroarginine methyl ester (50 mg/kg) (for 0.5 hours) and meclofenamate (3 mg/kg) (for 0.5 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
arterial blood pressure trait |
male |
16.0 days
| 5 |
undefined |
|
137.0 |
mmHg |
3.0 |
6.71 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
103033 |
2784 |
| Crlj:WI |
heart rate |
controlled air oxygen content (21 %) (for 28 days) then vehicle control condition (0.15 ml) (for 0.1 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) then sodium nitroprusside (5 ug/kg/min) (for 0.1 hours) then NG-nitroarginine methyl ester (50 mg/kg) (for 0.5 hours) then meclofenamate (3 mg/kg) (for 0.5 hours) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
heart pumping trait |
male |
16.0 days
| 6 |
|
|
288.0 |
beats/min |
11.0 |
26.94 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
103047 |
2784 |
| Crlj:WI |
heart rate |
controlled air oxygen content (5 %) (for 28 days) then vehicle control condition (0.15 ml) (for 0.1 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) then sodium nitroprusside (5 ug/kg/min) (for 0.1 hours) then NG-nitroarginine methyl ester (50 mg/kg) (for 0.5 hours) and meclofenamate (3 mg/kg) (for 0.5 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
heart pumping trait |
male |
16.0 days
| 7 |
|
|
264.0 |
beats/min |
9.0 |
23.81 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
103052 |
2784 |
| ACI.FHH-(rs105487995-rs106411696)/Mcwi |
urine albumin excretion rate |
unilateral nephrectomy then NG-nitroarginine methyl ester (150 mg/l) (for 56 days) |
Lazar J, et al., Physiol Genomics. 2013 Aug 15;45(16):720-8. doi: 10.1152/physiolgenomics.00089.2013. Epub 2013 Jun 18. |
urine albumin amount |
male |
91.0 days
| 8 |
|
|
33.72 |
mg/d |
6.92 |
19.57 |
urine albumin analysis |
|
0.0 |
unx |
56 |
days |
|
rf-1-2 |
100061 |
2400 |
| BN/NHsdMcwi |
ratio of change in renal blood flow rate to kidney weight |
controlled sodium content diet (0.4 %) (for 16 hours) then NG-nitroarginine methyl ester (5 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
renal blood flow trait |
female |
97.0 days-101.0 days |
20 |
|
|
-1.2 |
ml/min/g |
0.7 |
3.13 |
electromagnetic flowmetry |
|
0.0 |
|
|
|
electromagnetic flowmetry |
|
67309 |
151 |
| HTG |
systolic blood pressure |
losartan (10 mg/kg) (for 0.2 hours) then pentolinium (5 mg/kg) (for 0.1 hours) then NG-nitroarginine methyl ester (30 mg/kg) (for 0.3 hours) |
Ueno T, et al., Physiol Res 2003;52(6):689-700. |
arterial blood pressure trait |
not specified |
days
| 10 |
|
continuous mean |
163.4 |
mmHg |
|
|
vascular indwelling catheter method |
|
|
|
|
|
|
|
65381 |
568 |
| HTG |
diastolic blood pressure |
losartan (10 mg/kg) (for 0.2 hours) then pentolinium (5 mg/kg) (for 0.1 hours) then NG-nitroarginine methyl ester (30 mg/kg) (for 0.3 hours) |
Ueno T, et al., Physiol Res 2003;52(6):689-700. |
arterial blood pressure trait |
not specified |
days
| 10 |
|
continuous mean |
108.8 |
mmHg |
|
|
vascular indwelling catheter method |
|
|
|
|
|
|
|
65387 |
568 |
| LEW/Cub |
heart weight to body weight ratio |
losartan (10 mg/kg) (for 0.2 hours) then pentolinium (5 mg/kg) (for 0.1 hours) then NG-nitroarginine methyl ester (30 mg/kg) (for 0.3 hours) |
Ueno T, et al., Physiol Res 2003;52(6):689-700. |
heart mass |
not specified |
days
| 9 |
|
|
2.5 |
g/kg |
|
|
post excision weight measurement |
|
0 |
|
|
|
|
|
65413 |
568 |
| HTG |
both kidneys wet weight to body weight ratio |
losartan (10 mg/kg) (for 0.2 hours) then pentolinium (5 mg/kg) (for 0.1 hours) then NG-nitroarginine methyl ester (30 mg/kg) (for 0.3 hours) |
Ueno T, et al., Physiol Res 2003;52(6):689-700. |
kidney mass |
not specified |
days
| 10 |
|
continuous mean |
5.92 |
g/kg |
|
|
post excision weight measurement |
|
0 |
|
|
|
|
|
65418 |
568 |
| ACI/Eur |
body weight |
NG-nitroarginine methyl ester (50-150 mg/l) |
Van Dijk SJ, et al., Kidney Int. 2006 |
body mass |
male |
168.0 days-175.0 days |
12 |
|
|
319.0 |
g |
5.0 |
17.32 |
body weighing method |
|
0.0 |
|
|
|
|
|
67700 |
62 |
| SS.MNS-(D2Mit6-D2Rat303)/Ayd |
blood vessel contractile force measurement |
Kreb's solution perfusate then potassium chloride solution (40 mmol/l) and NG-nitroarginine methyl ester (100 umol/l) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
vasoconstriction trait |
male |
98.0 days
| 13 |
|
|
1.6 |
g |
0.12 |
0.43 |
tissue force analysis utilizing a force transducer |
|
0.0 |
|
|
|
isometric force transducer |
|
69051 |
1096 |
| SS/Jr |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
Kreb's solution perfusate then phenylephrine (1-100 mmol/l) and NG-nitroarginine methyl ester (100 umol/l) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
vasoconstriction trait |
male |
98.0 days
| 12 |
|
|
-7.6 |
null |
0.05 |
0.17 |
tissue force analysis utilizing a force transducer |
|
0.0 |
|
|
|
isometric force transducer |
EC50 value is probably moles/liter |
69058 |
1096 |
| ACI.FHH-(D1Rat384-D1Rat452)(D17Rat61-D1Arb5)(D17Rat51)/Eur |
body weight |
NG-nitroarginine methyl ester (9-16 mg/kg/d) (for 126 days) |
van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12. |
body mass |
not specified |
168.0 days-175.0 days |
12 |
|
|
296.0 |
g |
5.0 |
17.32 |
body weighing method |
|
0.0 |
|
|
|
|
|
67938 |
832 |
| BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) then acetylcholine (0.2 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
17 |
|
serial mean |
144.9 |
mmHg |
3.1 |
12.78 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
|
|
69549 |
151 |
| ACI.FHH-(D1Mit18-D1Mit8)(D14Mit11-D14Hmgc14b)(D14Rat65-D14Rat90)/Eur |
body weight |
unilateral nephrectomy then NG-nitroarginine methyl ester (10-21 ml/kg/d) (for 126 days) |
van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12. |
body mass |
not specified |
168.0 days-175.0 days |
2 |
|
|
286.0 |
g |
1.0 |
1.41 |
body weighing method |
|
0.0 |
unilateral nephrectomy |
126 |
days |
|
|
67909 |
832 |
| ACI.FHH-(D1Rat384-D1Rat452)(D17Rat61-D1Arb5)(D17Rat51)/Eur |
body weight |
unilateral nephrectomy then NG-nitroarginine methyl ester (10-21 ml/kg/d) (for 126 days) |
van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12. |
body mass |
not specified |
168.0 days-175.0 days |
9 |
|
|
277.0 |
g |
6.0 |
18.0 |
body weighing method |
|
0.0 |
unilateral nephrectomy |
126 |
days |
|
|
67910 |
832 |
| SS/HsdMcwiCrl |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled carbohydrate content diet (53 %) (for 63 days) and controlled fat content diet (14 %) (for 63 days) and controlled protein content diet (33 %) (for 63 days) then controlled carbohydrate content diet (69 %) (for 28 days) and controlled fat content diet (12 %) (for 28 days) and controlled protein content diet (19 %) (for 28 days) then phenylephrine (2 umol/l) then NG-nitroarginine methyl ester (100 umol/l) then acetylcholine (3.16 umol/l) |
Spradley FT, et al., Am J Physiol Regul Integr Comp Physiol. 2012 Jan 1;302(1):R150-8. Epub 2011 Oct 26. |
vasodilation trait |
male |
112.0 days
| 10 |
[(maximum PE response − ACh response)/(maximum PE response − baseline before PE constriction)] × 100 |
|
64.5 |
% |
15.34 |
48.51 |
wire myography |
mesenteric artery |
0.0 |
|
|
|
|
|
69621 |
735 |
| ACI.FHH-(D3Wox2-D3Rat59)/Eur |
kidney sclerotic glomeruli count to total glomeruli count ratio |
right nephrectomy then NG-nitroarginine methyl ester (50-150 mg/l) |
Van Dijk SJ, et al., Kidney Int. 2006 |
kidney glomerulus integrity trait |
male |
168.0 days-175.0 days |
11 |
|
|
39.0 |
% |
5.0 |
16.58 |
ex vivo light microscopy |
|
0.0 |
|
|
|
|
|
67723 |
62 |
| ACI/Eur |
kidney sclerotic glomeruli count to total glomeruli count ratio |
right nephrectomy then NG-nitroarginine methyl ester (50-150 mg/l) |
Van Dijk SJ, et al., Kidney Int. 2006 |
kidney glomerulus integrity trait |
male |
168.0 days-175.0 days |
12 |
|
|
15.0 |
% |
1.0 |
3.46 |
ex vivo light microscopy |
|
0.0 |
|
|
|
|
|
67722 |
62 |
| ACI.FHH-(D3Wox2-D3Rat59)/Eur |
creatinine clearance to body weight ratio |
NG-nitroarginine methyl ester (50-150 mg/l) |
Van Dijk SJ, et al., Kidney Int. 2006 |
glomerular filtration trait |
male |
168.0 days-175.0 days |
12 |
|
|
0.78 |
ml/min/100g |
0.04 |
0.14 |
blood creatinine analysis |
|
0.0 |
|
|
|
|
|
67732 |
62 |
| ACI.FHH-(D1Rat475-D1Rat90)(D3Rat84-D3Rat59)/Eur |
creatinine clearance to body weight ratio |
NG-nitroarginine methyl ester (50-150 mg/l) |
Van Dijk SJ, et al., Kidney Int. 2006 |
glomerular filtration trait |
male |
168.0 days-175.0 days |
12 |
|
|
0.52 |
ml/min/100g |
0.04 |
0.14 |
blood creatinine analysis |
|
0.0 |
|
|
|
|
|
67734 |
62 |
| ACI.FHH-(D1Rat298-D1Rat90)/Eur |
creatinine clearance to body weight ratio |
right nephrectomy then NG-nitroarginine methyl ester (50-150 mg/l) |
Van Dijk SJ, et al., Kidney Int. 2006 |
glomerular filtration trait |
male |
168.0 days-175.0 days |
12 |
|
|
0.4 |
ml/min/100g |
0.03 |
0.1 |
blood creatinine analysis |
|
0.0 |
|
|
|
|
|
67742 |
62 |
| ACI.FHH-(D1Rat475-D1Rat90)(D3Rat84-D3Rat59)/Eur |
creatinine clearance to body weight ratio |
right nephrectomy then NG-nitroarginine methyl ester (50-150 mg/l) |
Van Dijk SJ, et al., Kidney Int. 2006 |
glomerular filtration trait |
male |
168.0 days-175.0 days |
5 |
|
|
0.31 |
ml/min/100g |
0.06 |
0.13 |
blood creatinine analysis |
|
0.0 |
|
|
|
|
|
67743 |
62 |
| ACI.FHH-(D1Rat384-D1Rat452)(D17Rat61-D1Arb5)(D17Rat51)/Eur |
kidney sclerotic glomeruli count to total glomeruli count ratio |
NG-nitroarginine methyl ester (9-16 mg/kg/d) (for 126 days) |
van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12. |
kidney glomerulus integrity trait |
not specified |
168.0 days-175.0 days |
12 |
|
|
14.0 |
% |
7.0 |
24.25 |
ex vivo light microscopy |
|
0.0 |
|
|
|
|
Original CMO_ID, CMO:0001176, was merged into current ID and field automatically updated. 4-26-2013 |
68889 |
832 |
| ACI.FHH-(D1Mit18-D1Mit8)(D14Mit11-D14Hmgc14b)(D14Rat65-D14Rat90)/Eur |
kidney sclerotic glomeruli count to total glomeruli count ratio |
NG-nitroarginine methyl ester (9-16 mg/kg/d) (for 126 days) |
van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12. |
kidney glomerulus integrity trait |
not specified |
168.0 days-175.0 days |
12 |
|
|
33.0 |
% |
3.0 |
10.39 |
ex vivo light microscopy |
|
0.0 |
|
|
|
|
Original CMO_ID, CMO:0001176, was merged into current ID and field automatically updated. 4-26-2013 |
68888 |
832 |
| ACI/Eur |
kidney sclerotic glomeruli count to total glomeruli count ratio |
NG-nitroarginine methyl ester (9-16 mg/kg/d) (for 126 days) |
van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12. |
kidney glomerulus integrity trait |
not specified |
168.0 days-175.0 days |
12 |
|
|
11.0 |
% |
1.0 |
3.46 |
ex vivo light microscopy |
|
0.0 |
|
|
|
|
Original CMO_ID, CMO:0001176, was merged into current ID and field automatically updated. 4-26-2013 |
68886 |
832 |
| SS/HsdMcwiCrl |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled carbohydrate content diet (53 %) (for 91 days) and controlled fat content diet (14 %) (for 91 days) and controlled protein content diet (33 %) (for 91 days) then phenylephrine (2 umol/l) then NG-nitroarginine methyl ester (100 umol/l) (for 0.2 hours) then acetylcholine (0.001-9.5 umol/l) |
Spradley FT, et al., Am J Physiol Regul Integr Comp Physiol. 2012 Jan 1;302(1):R150-8. Epub 2011 Oct 26. |
vasodilation trait |
male |
112.0 days
| 5 |
logEC50 |
|
-6.2 |
null |
0.1 |
0.22 |
wire myography |
mesenteric artery |
0.0 |
|
|
|
BCA assay |
|
84644 |
735 |
| SS/HsdMcwiCrl |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled carbohydrate content diet (69 %) (for 91 days) and controlled fat content diet (12 %) (for 91 days) and controlled protein content diet (19 %) (for 91 days) then phenylephrine (2 umol/l) then NG-nitroarginine methyl ester (100 umol/l) then acetylcholine (0.001-9.5 umol/l) |
Spradley FT, et al., Am J Physiol Regul Integr Comp Physiol. 2012 Jan 1;302(1):R150-8. Epub 2011 Oct 26. |
vasodilation trait |
male |
112.0 days
| 6 |
logEC50 |
|
-6.6 |
null |
0.1 |
0.24 |
wire myography |
mesenteric artery |
0.0 |
|
|
|
|
|
84646 |
735 |
| SS/HsdMcwiCrl |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled carbohydrate content diet (53 %) (for 63 days) and controlled fat content diet (14 %) (for 63 days) and controlled protein content diet (33 %) (for 63 days) then controlled carbohydrate content diet (69 %) (for 28 days) and controlled fat content diet (12 %) (for 28 days) and controlled protein content diet (19 %) (for 28 days) then phenylephrine (2 umol/l) then NG-nitroarginine methyl ester (100 umol/l) then acetylcholine (0.001-9.5 umol/l) |
Spradley FT, et al., Am J Physiol Regul Integr Comp Physiol. 2012 Jan 1;302(1):R150-8. Epub 2011 Oct 26. |
vasodilation trait |
male |
112.0 days
| 8 |
logEC50 |
|
-6.3 |
null |
0.2 |
0.57 |
wire myography |
mesenteric artery |
0.0 |
|
|
|
|
|
84645 |
735 |
| SS/HsdMcwiCrl |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled carbohydrate content diet (53 %) (for 91 days) and controlled fat content diet (14 %) (for 91 days) and controlled protein content diet (33 %) (for 91 days) then phenylephrine (1 umol/l) then NG-nitroarginine methyl ester (100 umol/l) (for 0.2 hours) then acetylcholine (31.6 umol/l) |
Spradley FT, et al., Am J Physiol Regul Integr Comp Physiol. 2012 Jan 1;302(1):R150-8. Epub 2011 Oct 26. |
vasodilation trait |
male |
112.0 days
| 6 |
[(maximum PE response − ACh response)/(maximum PE response − baseline before PE constriction)] × 100 |
|
-19.03 |
% |
4.01 |
9.82 |
wire myography |
aorta |
0.0 |
|
|
|
BCA assay |
|
84656 |
735 |
| SS/HsdMcwiCrl |
phenylephrine-induced blood vessel contractile force expressed as percent of force at baseline |
controlled carbohydrate content diet (69 %) (for 91 days) and controlled fat content diet (12 %) (for 91 days) and controlled protein content diet (19 %) (for 91 days) then NG-nitroarginine methyl ester (100 umol/l) (for 0.2 hours) then phenylephrine (31.6 umol/l) |
Spradley FT, et al., Am J Physiol Regul Integr Comp Physiol. 2012 Jan 1;302(1):R150-8. Epub 2011 Oct 26. |
vasoconstriction trait |
male |
112.0 days
| 6 |
[(response to vasoconstrictor - baseline before constriction)/baseline before constriction] x 100 |
|
564.27 |
% |
57.82 |
141.63 |
wire myography |
mesenteric artery |
0.0 |
|
|
|
|
phenylephrine-induced blood vessel constriction expressed as percent of force at baseline |
84678 |
735 |
| Crlj:WI |
mean arterial blood pressure |
controlled air oxygen content (21 %) (for 28 days) then vehicle control condition (0.15 ml) (for 0.1 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) then sodium nitroprusside (5 ug/kg/min) (for 0.1 hours) then NG-nitroarginine methyl ester (50 mg/kg) (for 0.5 hours) then meclofenamate (3 mg/kg) (for 0.5 hours) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
arterial blood pressure trait |
male |
16.0 days
| 6 |
undefined |
|
155.0 |
mmHg |
10.0 |
24.49 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
103027 |
2784 |
| GK |
mean arterial blood pressure |
controlled air oxygen content (21 %) (for 28 days) then vehicle control condition (0.15 ml) (for 0.1 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) then sodium nitroprusside (5 ug/kg/min) (for 0.1 hours) then NG-nitroarginine methyl ester (50 mg/kg) (for 0.5 hours) and meclofenamate (3 mg/kg) (for 0.5 hours) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
arterial blood pressure trait |
male |
16.0 days
| 5 |
undefined |
|
151.0 |
mmHg |
1.0 |
2.24 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
103029 |
2784 |
| GK |
heart rate |
controlled air oxygen content (21 %) (for 28 days) then vehicle control condition (0.15 ml) (for 0.1 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) then sodium nitroprusside (5 ug/kg/min) (for 0.1 hours) then NG-nitroarginine methyl ester (50 mg/kg) (for 0.5 hours) and meclofenamate (3 mg/kg) (for 0.5 hours) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
heart pumping trait |
male |
16.0 days
| 5 |
|
|
301.0 |
beats/min |
21.0 |
46.96 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
103049 |
2784 |
| ACI.FHH-(rs105487995-rs105373896)/Mcwi |
urine total protein excretion rate |
unilateral nephrectomy then NG-nitroarginine methyl ester (150 mg/l) (for 56 days) |
Lazar J, et al., Physiol Genomics. 2013 Aug 15;45(16):720-8. doi: 10.1152/physiolgenomics.00089.2013. Epub 2013 Jun 18. |
total urine protein amount |
male |
91.0 days
| 8 |
|
|
62.94 |
mg/d |
7.34 |
20.76 |
urine protein analysis |
|
0.0 |
unx |
56 |
days |
|
rf-1-1 |
100052 |
2400 |
| ACI.FHH-(rgdv393055223-rs198922144)/Mcwi |
urine total protein excretion rate |
unilateral nephrectomy then NG-nitroarginine methyl ester (150 mg/l) (for 56 days) |
Lazar J, et al., Physiol Genomics. 2013 Aug 15;45(16):720-8. doi: 10.1152/physiolgenomics.00089.2013. Epub 2013 Jun 18. |
total urine protein amount |
male |
91.0 days
| 7 |
|
|
173.13 |
mg/d |
18.71 |
49.5 |
urine protein analysis |
|
0.0 |
unx |
56 |
days |
|
rf-1-4 |
100055 |
2400 |
| ACI.FHH-(rgdv393055223-rs198076037)/Mcwi |
urine albumin excretion rate |
unilateral nephrectomy then NG-nitroarginine methyl ester (150 mg/l) (for 56 days) |
Lazar J, et al., Physiol Genomics. 2013 Aug 15;45(16):720-8. doi: 10.1152/physiolgenomics.00089.2013. Epub 2013 Jun 18. |
urine albumin amount |
male |
91.0 days
| 7 |
|
|
27.46 |
mg/d |
3.8 |
10.05 |
urine albumin analysis |
|
0.0 |
unx |
56 |
days |
|
rf-1-5 |
100064 |
2400 |
| HTG |
mean arterial blood pressure |
losartan (10 mg/kg) (for 0.2 hours) then pentolinium (5 mg/kg) (for 0.1 hours) then NG-nitroarginine methyl ester (30 mg/kg) (for 0.3 hours) |
Ueno T, et al., J Mol Med 2003 Jan;81(1):51-60. Epub 2002 Nov 21. |
arterial blood pressure trait |
both |
151.0 days-181.0 days |
19 |
|
continuous mean |
139.0 |
mmHg |
5.0 |
21.79 |
vascular indwelling catheter method |
carotid artery, jugular vein |
1800 |
|
|
|
|
|
64705 |
249 |
| SS.BN-(D13Hmgc41-D13Hmgc23)/Mcwi |
middle cerebral artery inner diameter |
controlled calcium ion content physiological salt solution perfusate (0 %) then NG-nitroarginine methyl ester (100 umol/l) (for 0.3 hours) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63.0 days-98.0 days |
7 |
|
|
255.0 |
um |
5.2 |
13.76 |
ex vivo videomicroscopy |
|
0.0 |
|
|
|
|
|
69556 |
732 |
| SS.BN-(D13Hmgc41-D13Hmgc23)/Mcwi |
middle cerebral artery inner diameter |
physiological salt solution perfusate then NG-nitroarginine methyl ester (100 umol/l) (for 0.3 hours) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63.0 days-98.0 days |
7 |
|
|
131.0 |
um |
5.7 |
15.08 |
ex vivo videomicroscopy |
|
0.0 |
|
|
|
|
|
69555 |
732 |
| SS/Jr |
receptor-dependent blood vessel maximum contractile force to receptor-independent blood vessel maximum contractile force ratio |
Kreb's solution perfusate then angiotensin II (0.3-300 umol/l) and NG-nitroarginine methyl ester (100 umol/l) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
vasoconstriction trait |
male |
98.0 days
| 12 |
|
|
50.61 |
% |
5.29 |
18.33 |
tissue force analysis utilizing a force transducer |
|
0.0 |
|
|
|
isometric force transducer |
|
69069 |
1096 |
| SS/JrHsdMcwi |
middle cerebral artery inner diameter |
controlled tempol content drinking water (15 mg/kg/d) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) then NG-nitroarginine methyl ester (100 umol/l) (for 0.3 hours) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63.0 days-98.0 days |
6 |
|
|
246.0 |
um |
8.9 |
21.8 |
ex vivo videomicroscopy |
|
0.0 |
|
|
|
|
|
69586 |
732 |
| ACI/Eur |
body weight |
NG-nitroarginine methyl ester (9-16 mg/kg/d) (for 126 days) |
van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12. |
body mass |
not specified |
168.0 days-175.0 days |
12 |
|
|
314.0 |
g |
6.0 |
20.78 |
body weighing method |
|
0.0 |
|
|
|
|
|
67935 |
832 |
| ACI.FHH-(D1Mit18-D1Mit8)(D14Mit11-D14Hmgc14b)(D14Rat65-D14Rat90)/Eur |
body weight |
NG-nitroarginine methyl ester (9-16 mg/kg/d) (for 126 days) |
van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12. |
body mass |
not specified |
168.0 days-175.0 days |
12 |
|
|
285.0 |
g |
8.0 |
27.71 |
body weighing method |
|
0.0 |
|
|
|
|
|
67937 |
832 |
| ACI/Eur |
body weight |
unilateral nephrectomy then NG-nitroarginine methyl ester (10-21 ml/kg/d) (for 126 days) |
van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12. |
body mass |
not specified |
168.0 days-175.0 days |
12 |
|
|
314.0 |
g |
5.0 |
17.32 |
body weighing method |
|
0.0 |
unilateral nephrectomy |
126 |
days |
|
|
67907 |
832 |
| SS/HsdMcwiCrl |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled carbohydrate content diet (53 %) (for 91 days) and controlled fat content diet (14 %) (for 91 days) and controlled protein content diet (33 %) (for 91 days) then phenylephrine (2 umol/l) then NG-nitroarginine methyl ester (100 umol/l) (for 0.2 hours) then acetylcholine (3.16 umol/l) |
Spradley FT, et al., Am J Physiol Regul Integr Comp Physiol. 2012 Jan 1;302(1):R150-8. Epub 2011 Oct 26. |
vasodilation trait |
male |
112.0 days
| 5 |
[(maximum PE response − ACh response)/(maximum PE response − baseline before PE constriction)] × 100 |
|
94.99 |
% |
0.39 |
0.87 |
wire myography |
mesenteric artery |
0.0 |
|
|
|
BCA assay |
|
69620 |
735 |
| ACI.FHH-(D3Wox2-D3Rat59)/Eur |
creatinine clearance to body weight ratio |
right nephrectomy then NG-nitroarginine methyl ester (50-150 mg/l) |
Van Dijk SJ, et al., Kidney Int. 2006 |
glomerular filtration trait |
male |
168.0 days-175.0 days |
11 |
|
|
0.63 |
ml/min/100g |
0.04 |
0.13 |
blood creatinine analysis |
|
0.0 |
|
|
|
|
|
67741 |
62 |
| ACI/Eur |
creatinine clearance to body weight ratio |
right nephrectomy then NG-nitroarginine methyl ester (50-150 mg/l) |
Van Dijk SJ, et al., Kidney Int. 2006 |
glomerular filtration trait |
male |
168.0 days-175.0 days |
12 |
|
|
0.46 |
ml/min/100g |
0.05 |
0.17 |
blood creatinine analysis |
|
0.0 |
|
|
|
|
|
67740 |
62 |
| ACI.FHH-(D1Rat384-D1Rat156)/Eur |
kidney sclerotic glomeruli count to total glomeruli count ratio |
unilateral nephrectomy then NG-nitroarginine methyl ester (10-21 mg/kg/d) (for 126 days) |
van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12. |
kidney glomerulus integrity trait |
not specified |
168.0 days-175.0 days |
11 |
|
|
42.0 |
% |
6.0 |
19.9 |
ex vivo light microscopy |
|
0.0 |
unilateral nephrectomy |
126 |
days |
|
Original CMO_ID, CMO:0001176, was merged into current ID and field automatically updated. 4-26-2013 |
68883 |
832 |
| SS/HsdMcwiCrl |
phenylephrine-induced blood vessel contractile force expressed as percent of force at baseline |
controlled carbohydrate content diet (69 %) (for 63 days) and controlled fat content diet (12 %) (for 63 days) and controlled protein content diet (19 %) (for 63 days) then controlled carbohydrate content diet (53 %) (for 28 days) and controlled fat content diet (14 %) (for 28 days) and controlled protein content diet (33 %) (for 28 days) then NG-nitroarginine methyl ester (100 umol/l) (for 0.2 hours) then phenylephrine (31.6 umol/l) |
Spradley FT, et al., Am J Physiol Regul Integr Comp Physiol. 2012 Jan 1;302(1):R150-8. Epub 2011 Oct 26. |
vasoconstriction trait |
male |
112.0 days
| 5 |
[(response to vasoconstrictor - baseline before constriction)/baseline before constriction] x 100 |
|
665.33 |
% |
79.91 |
178.68 |
wire myography |
mesenteric artery |
0.0 |
|
|
|
|
phenylephrine-induced blood vessel constriction expressed as percent of force at baseline |
84679 |
735 |
| GK |
mean arterial blood pressure |
controlled air oxygen content (5 %) (for 28 days) then vehicle control condition (0.15 ml) (for 0.1 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) then sodium nitroprusside (5 ug/kg/min) (for 0.1 hours) then NG-nitroarginine methyl ester (50 mg/kg) (for 0.5 hours) and meclofenamate (3 mg/kg) (for 0.5 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
arterial blood pressure trait |
male |
16.0 days
| 7 |
undefined |
|
143.0 |
mmHg |
3.0 |
7.94 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
103034 |
2784 |
| GK |
heart rate |
controlled air oxygen content (5 %) (for 28 days) then vehicle control condition (0.15 ml) (for 0.1 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) then sodium nitroprusside (5 ug/kg/min) (for 0.1 hours) then NG-nitroarginine methyl ester (50 mg/kg) (for 0.5 hours) and meclofenamate (3 mg/kg) (for 0.5 hours) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
heart pumping trait |
male |
16.0 days
| 7 |
|
|
344.0 |
beats/min |
11.0 |
29.1 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
103050 |
2784 |
| GK |
heart rate |
controlled air oxygen content (5 %) (for 28 days) then vehicle control condition (0.15 ml) (for 0.1 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) then sodium nitroprusside (5 ug/kg/min) (for 0.1 hours) then NG-nitroarginine methyl ester (50 mg/kg) (for 0.5 hours) and meclofenamate (3 mg/kg) (for 0.5 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
heart pumping trait |
male |
16.0 days
| 7 |
|
|
279.0 |
beats/min |
17.0 |
44.98 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
103054 |
2784 |
| ACI.FHH-(rgdv393055223-rs107095981)/Mcwi |
urine total protein excretion rate |
unilateral nephrectomy then NG-nitroarginine methyl ester (150 mg/l) (for 56 days) |
Lazar J, et al., Physiol Genomics. 2013 Aug 15;45(16):720-8. doi: 10.1152/physiolgenomics.00089.2013. Epub 2013 Jun 18. |
total urine protein amount |
male |
91.0 days
| 5 |
|
|
188.71 |
mg/d |
20.03 |
44.79 |
urine protein analysis |
|
0.0 |
unx |
56 |
days |
|
rf-1-3 |
100054 |
2400 |
| ACI.FHH-(rs198076037-rs105278863)/Mcwi |
urine total protein excretion rate |
unilateral nephrectomy then NG-nitroarginine methyl ester (150 mg/l) (for 56 days) |
Lazar J, et al., Physiol Genomics. 2013 Aug 15;45(16):720-8. doi: 10.1152/physiolgenomics.00089.2013. Epub 2013 Jun 18. |
total urine protein amount |
male |
91.0 days
| 5 |
|
|
154.55 |
mg/d |
13.31 |
29.76 |
urine protein analysis |
|
0.0 |
unx |
56 |
days |
|
rf-1-7 |
100058 |
2400 |
| SS/JrHsdMcwi |
ratio of change in renal blood flow rate to kidney weight |
controlled sodium content diet (0.4 %) (for 16 hours) then NG-nitroarginine methyl ester (5 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
renal blood flow trait |
female |
97.0 days-101.0 days |
9 |
|
|
1.9 |
ml/min/g |
0.5 |
1.5 |
electromagnetic flowmetry |
|
0.0 |
|
|
|
electromagnetic flowmetry |
|
67310 |
151 |
| LEW/Cub |
diastolic blood pressure |
losartan (10 mg/kg) (for 0.2 hours) then pentolinium (5 mg/kg) (for 0.1 hours) then NG-nitroarginine methyl ester (30 mg/kg) (for 0.3 hours) |
Ueno T, et al., Physiol Res 2003;52(6):689-700. |
arterial blood pressure trait |
not specified |
days
| 9 |
|
continuous mean |
82.5 |
mmHg |
|
|
vascular indwelling catheter method |
|
|
|
|
|
|
|
65392 |
568 |
| SS.MNS-(D2Mit6-D2Rat303)/Ayd |
receptor-dependent blood vessel maximum contractile force to receptor-independent blood vessel maximum contractile force ratio |
Kreb's solution perfusate then angiotensin II (0.3-300 umol/l) and NG-nitroarginine methyl ester (100 umol/l) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
vasoconstriction trait |
male |
98.0 days
| 13 |
|
|
26.63 |
% |
4.0 |
14.42 |
tissue force analysis utilizing a force transducer |
|
0.0 |
|
|
|
isometric force transducer |
|
69070 |
1096 |
| SS/Jr |
blood vessel contractile force measurement |
Kreb's solution perfusate then potassium chloride solution (40 mmol/l) and NG-nitroarginine methyl ester (100 umol/l) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
vasoconstriction trait |
male |
98.0 days
| 12 |
|
|
1.39 |
g |
0.06 |
0.21 |
tissue force analysis utilizing a force transducer |
|
0.0 |
|
|
|
isometric force transducer |
|
69050 |
1096 |
| SS.MNS-(D2Mit6-D2Rat303)/Ayd |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
Kreb's solution perfusate then phenylephrine (1-100 mmol/l) and NG-nitroarginine methyl ester (100 umol/l) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
vasoconstriction trait |
male |
98.0 days
| 13 |
|
|
-7.41 |
null |
0.16 |
0.58 |
tissue force analysis utilizing a force transducer |
|
0.0 |
|
|
|
isometric force transducer |
EC50 value is probably moles/liter |
69059 |
1096 |
| ACI.FHH-(D1Rat384-D1Rat156)/Eur |
body weight |
NG-nitroarginine methyl ester (9-16 mg/kg/d) (for 126 days) |
van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12. |
body mass |
not specified |
168.0 days-175.0 days |
12 |
|
|
292.0 |
g |
5.0 |
17.32 |
body weighing method |
|
0.0 |
|
|
|
|
|
67936 |
832 |
| BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
21 |
|
serial mean |
137.4 |
mmHg |
4.0 |
18.33 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
|
|
69545 |
151 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
9 |
|
serial mean |
159.0 |
mmHg |
7.1 |
21.3 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
|
|
69546 |
151 |
| SS/HsdMcwiCrl |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled carbohydrate content diet (69 %) (for 63 days) and controlled fat content diet (12 %) (for 63 days) and controlled protein content diet (19 %) (for 63 days) then controlled carbohydrate content diet (53 %) (for 28 days) and controlled fat content diet (14 %) (for 28 days) and controlled protein content diet (33 %) (for 28 days) then phenylephrine (2 umol/l) then NG-nitroarginine methyl ester (100 umol/l) then acetylcholine (3.16 umol/l) |
Spradley FT, et al., Am J Physiol Regul Integr Comp Physiol. 2012 Jan 1;302(1):R150-8. Epub 2011 Oct 26. |
vasodilation trait |
male |
112.0 days
| 6 |
[(maximum PE response − ACh response)/(maximum PE response − baseline before PE constriction)] × 100 |
|
92.95 |
% |
1.46 |
3.58 |
wire myography |
mesenteric artery |
0.0 |
|
|
|
|
|
69623 |
735 |
| ACI.FHH-(D1Rat475-D1Rat90)(D3Rat84-D3Rat59)/Eur |
body weight |
right nephrectomy then NG-nitroarginine methyl ester (50-150 mg/l) |
Van Dijk SJ, et al., Kidney Int. 2006 |
body mass |
male |
168.0 days-175.0 days |
5 |
|
|
263.0 |
g |
12.0 |
26.83 |
body weighing method |
|
0.0 |
|
|
|
|
|
67707 |
62 |
| ACI.FHH-(D1Rat298-D1Rat90)/Eur |
kidney sclerotic glomeruli count to total glomeruli count ratio |
NG-nitroarginine methyl ester (50-150 mg/l) |
Van Dijk SJ, et al., Kidney Int. 2006 |
kidney glomerulus integrity trait |
male |
168.0 days-175.0 days |
12 |
|
|
23.0 |
% |
2.0 |
6.93 |
ex vivo light microscopy |
|
0.0 |
|
|
|
|
|
67715 |
62 |
| ACI.FHH-(D1Rat475-D1Rat90)(D3Rat84-D3Rat59)/Eur |
kidney sclerotic glomeruli count to total glomeruli count ratio |
NG-nitroarginine methyl ester (50-150 mg/l) |
Van Dijk SJ, et al., Kidney Int. 2006 |
kidney glomerulus integrity trait |
male |
168.0 days-175.0 days |
12 |
|
|
31.0 |
% |
6.0 |
20.78 |
ex vivo light microscopy |
|
0.0 |
|
|
|
|
|
67716 |
62 |
| ACI.FHH-(D1Rat298-D1Rat90)/Eur |
creatinine clearance to body weight ratio |
NG-nitroarginine methyl ester (50-150 mg/l) |
Van Dijk SJ, et al., Kidney Int. 2006 |
glomerular filtration trait |
male |
168.0 days-175.0 days |
12 |
|
|
0.49 |
ml/min/100g |
0.01 |
0.03 |
blood creatinine analysis |
|
0.0 |
|
|
|
|
|
67733 |
62 |
| SS/HsdMcwiCrl |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled carbohydrate content diet (69 %) (for 63 days) and controlled fat content diet (12 %) (for 63 days) and controlled protein content diet (19 %) (for 63 days) then controlled carbohydrate content diet (53 %) (for 28 days) and controlled fat content diet (14 %) (for 28 days) and controlled protein content diet (33 %) (for 28 days) then phenylephrine (1 umol/l) then NG-nitroarginine methyl ester (100 umol/l) then acetylcholine (31.6 umol/l) |
Spradley FT, et al., Am J Physiol Regul Integr Comp Physiol. 2012 Jan 1;302(1):R150-8. Epub 2011 Oct 26. |
vasodilation trait |
male |
112.0 days
| 6 |
[(maximum PE response − ACh response)/(maximum PE response − baseline before PE constriction)] × 100 |
|
-16.62 |
% |
7.27 |
17.81 |
wire myography |
aorta |
0.0 |
|
|
|
|
|
84659 |
735 |
| GK |
mean arterial blood pressure |
controlled air oxygen content (5 %) (for 28 days) then vehicle control condition (0.15 ml) (for 0.1 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) then sodium nitroprusside (5 ug/kg/min) (for 0.1 hours) then NG-nitroarginine methyl ester (50 mg/kg) (for 0.5 hours) and meclofenamate (3 mg/kg) (for 0.5 hours) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
arterial blood pressure trait |
male |
16.0 days
| 7 |
undefined |
|
140.0 |
mmHg |
8.0 |
21.17 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
103030 |
2784 |
| GK |
heart rate |
controlled air oxygen content (21 %) (for 28 days) then vehicle control condition (0.15 ml) (for 0.1 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) then sodium nitroprusside (5 ug/kg/min) (for 0.1 hours) then NG-nitroarginine methyl ester (50 mg/kg) (for 0.5 hours) and meclofenamate (3 mg/kg) (for 0.5 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
heart pumping trait |
male |
16.0 days
| 5 |
|
|
252.0 |
beats/min |
25.0 |
55.9 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
103053 |
2784 |
| ACI.FHH-(rgdv393055223-rs198076037)/Mcwi |
urine total protein excretion rate |
unilateral nephrectomy then NG-nitroarginine methyl ester (150 mg/l) (for 56 days) |
Lazar J, et al., Physiol Genomics. 2013 Aug 15;45(16):720-8. doi: 10.1152/physiolgenomics.00089.2013. Epub 2013 Jun 18. |
total urine protein amount |
male |
91.0 days
| 7 |
|
|
67.24 |
mg/d |
4.02 |
10.64 |
urine protein analysis |
|
0.0 |
unx |
56 |
days |
|
rf-1-5 |
100056 |
2400 |
| ACI.FHH-(rs105487995-rs105373896)/Mcwi |
urine albumin excretion rate |
unilateral nephrectomy then NG-nitroarginine methyl ester (150 mg/l) (for 56 days) |
Lazar J, et al., Physiol Genomics. 2013 Aug 15;45(16):720-8. doi: 10.1152/physiolgenomics.00089.2013. Epub 2013 Jun 18. |
urine albumin amount |
male |
91.0 days
| 8 |
|
|
18.95 |
mg/d |
2.93 |
8.29 |
urine albumin analysis |
|
0.0 |
unx |
56 |
days |
|
rf-1-1 |
100060 |
2400 |
| ACI.FHH-(rgdv393055223-rs198922144)/Mcwi |
urine albumin excretion rate |
unilateral nephrectomy then NG-nitroarginine methyl ester (150 mg/l) (for 56 days) |
Lazar J, et al., Physiol Genomics. 2013 Aug 15;45(16):720-8. doi: 10.1152/physiolgenomics.00089.2013. Epub 2013 Jun 18. |
urine albumin amount |
male |
91.0 days
| 7 |
|
|
74.0 |
mg/d |
8.91 |
23.57 |
urine albumin analysis |
|
0.0 |
unx |
56 |
days |
|
rf-1-4 |
100063 |
2400 |
| ACI.FHH-(rs198076037-rs105278863)/Mcwi |
urine albumin excretion rate |
unilateral nephrectomy then NG-nitroarginine methyl ester (150 mg/l) (for 56 days) |
Lazar J, et al., Physiol Genomics. 2013 Aug 15;45(16):720-8. doi: 10.1152/physiolgenomics.00089.2013. Epub 2013 Jun 18. |
urine albumin amount |
male |
91.0 days
| 5 |
|
|
69.44 |
mg/d |
7.49 |
16.75 |
urine albumin analysis |
|
0.0 |
unx |
56 |
days |
|
rf-1-7 |
100066 |
2400 |